Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3042)
All Articles published online
|
Jun 15, 2001 (publication date) through Feb 8, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Zhuang L, You J, Tang BZ, Ding SY, Yan KH, Peng D, Zhang YM, Zhang L. Preliminary results of Thymosin-a1 vs interferon-α treatment in patients with HBeAg negative and serum HBV DNA positive chronic hepatitis B. World J Gastroenterol 2001; 7(3): 407-410 [PMID: PMC4688732 DOI: 10.3748/wjg.v7.i3.407] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v7/i3/407.htm |
| Number | Citing Articles |
| 1 |
A. Ciancio, M. Rizzetto. Thymalfasin in the treatment of hepatitis B and C. Annals of the New York Academy of Sciences 2010; 1194(1): 141 doi: 10.1111/j.1749-6632.2010.05487.x
|
| 2 |
S. Iino, J. Toyota, H. Kumada, K. Kiyosawa, S. Kakumu, M. Sata, H. Suzuki, E. B. Martins. The efficacy and safety of thymosin alpha‐1 in Japanese patients with chronic hepatitis B; results from a randomized clinical trial. Journal of Viral Hepatitis 2005; 12(3): 300 doi: 10.1111/j.1365-2893.2005.00633.x
|
| 3 |
C. Trépo, F. Zoulim. Traitement de l’hépatite B : progrès attendus. Gastroentérologie Clinique et Biologique 2009; 33(8-9): 811 doi: 10.1016/j.gcb.2009.04.005
|
| 4 |
Xiaoning Wu, Jidong Jia, Hong You. Thymosin alpha-1 treatment in chronic hepatitis B. Expert Opinion on Biological Therapy 2015; 15(sup1): 129 doi: 10.1517/14712598.2015.1007948
|
| 5 |
Hong-Lei Han, Zhen-Wei Lang. Changes in serum and histology of patients with chronic hepatitis B after interferon alpha-2b treatment. World Journal of Gastroenterology 2003; 9(1): 117-121 doi: 10.3748/wjg.v9.i1.117
|
| 6 |
Stephanos J Hadziyannis, George V Papatheodoridis. Emerging treatments in chronic hepatitis B. Expert Opinion on Emerging Drugs 2004; 9(2): 207 doi: 10.1517/14728214.9.2.207
|
| 7 |
Bo Hyun Kim, Youn-Jae Lee, Won Kim, Jung-Hwan Yoon, Eun Uk Jung, Sung Jae Park, Yoon Jun Kim, Hyo-Suk Lee. Efficacy of thymosin α-1 plus peginterferon α-2a combination therapy compared with peginterferon α-2a monotherapy in HBeAg-positive chronic hepatitis B: A prospective, multicenter, randomized, open-label study. Scandinavian Journal of Gastroenterology 2012; 47(8-9): 1048 doi: 10.3109/00365521.2012.694902
|
| 8 |
Haipeng Zhu, Ke Wang, Wei Du, Huanhuan Cao, Qingyang Zhong, Sichun Yin, Jianbo Zhong, Fawu Li. H3K9 acetylation modification and TLR9 immune regulation mechanism in patients after anti-HBV treatment. Medicine 2022; 101(52): e32431 doi: 10.1097/MD.0000000000032431
|
| 9 |
WANHU FAN, JUN CHENG, SHULIN ZHANG, XIAOJING LIU. Cloning and functions of the HBxAg-binding protein XBP1. Molecular Medicine Reports 2013; 7(2): 618 doi: 10.3892/mmr.2012.1232
|
| 10 |
Ying Chen, Johnny Sze, Ming-Liang He. HBV cccDNA in patients’ sera as an indicator for HBV reactivation and an early signal of liver damage. World Journal of Gastroenterology 2004; 10(1): 82-85 doi: 10.3748/wjg.v10.i1.82
|
| 11 |
Yu-Hu Song, Ju-Sheng Lin, Nan-Zhi Liu, Xin-Juan Kong, Na Xie, Nan-Xia Wang, You-Xin Jin, Kuo-Huan Liang. Anti-HBV hairpin ribozyme-mediated cleavage of target RNA <italic>in vitro</italic>. World Journal of Gastroenterology 2002; 8(1): 91-94 doi: 10.3748/wjg.v8.i1.91
|
| 12 |
ENRICO GARACI, CARTESIO FAVALLI, FRANCESCA PICA, PAOLA SINIBALDI VALLEBONA, ANNA TERESA PALAMARA, CLAUDIA MATTEUCCI, PASQUALE PIERIMARCHI, ANNALUCIA SERAFINO, ANTONIO MASTINO, FRANCESCO BISTONI, LUIGINA ROMANI, GUIDO RASI. Thymosin Alpha 1. Annals of the New York Academy of Sciences 2007; 1112(1): 225 doi: 10.1196/annals.1415.044
|
| 13 |
Yong-Feng Yang, Wei Zhao, Yan-Dan Zhong, Yi-Jun Yang, Ling Shen, Ning Zhang, Ping Huang. Comparison of the efficacy of thymosin alpha-1 and interferon alpha in the treatment of chronic hepatitis B: A meta-analysis. Antiviral Research 2008; 77(2): 136 doi: 10.1016/j.antiviral.2007.10.014
|
| 14 |
Raymund R. Razonable, James M. McGill. Hepatitis Prevention and Treatment. 2004; : 175 doi: 10.1007/978-3-0348-7903-3_10
|
| 15 |
Chun-Hong Ma, Wen-Sheng Sun, Pei-Kun Tian, Li-Fen Gao, Su-Xia Liu, Xiao-Yan Wang, Li-Ning Zhang, Ying-Lin Cao, Li-Hui Han, Xiao-Hong Liang. A novel HBV antisense RNA gene delivery system targeting hepatocellular carcinoma. World Journal of Gastroenterology 2003; 9(3): 463-467 doi: 10.3748/wjg.v9.i3.463
|
| 16 |
Yui-Jie Bai, Jin-Rong Zhao, Guan-Ting Lv, Wen-Hong Zhang, Yan Wang, Xiao-Jun Yan. Rapid and high throughput detection of HBV YMDD mutants with fluorescence polarization. World Journal of Gastroenterology 2003; 9(10): 2344-2347 doi: 10.3748/wjg.v9.i10.2344
|
| 17 |
Xiao-Ju Guan, Xiao-Jun Guan, Yu-Zhang Wu, Zheng-Cai Jia, Tong-Dong Shi, Yan Tang. Construction and characterization of an experimental ISCOMS-based hepatitis B polypeptide vaccine. World Journal of Gastroenterology 2002; 8(2): 294-297 doi: 10.3748/wjg.v8.i2.294
|
| 18 |
YUN‐FAN LIAW. Thymalfasin (thymosin‐alpha 1) therapy in patients with chronic hepatitis B. Journal of Gastroenterology and Hepatology 2004; 19(S6) doi: 10.1111/j.1440-1746.2004.03633.x
|
| 19 |
Roberto Camerini, Enrico Garaci. Historical review of thymosin α 1 in infectious diseases. Expert Opinion on Biological Therapy 2015; 15(sup1): 117 doi: 10.1517/14712598.2015.1033393
|
| 20 |
Murat Saruc, Nuri Ozden, Nurten Turkel, Semin Ayhan, Lynette M. Hock, Isil Tuzcuoglu, Hakan Yuceyar. Long-term outcomes of thymosin-α1 and interferon α-2b combination therapy in patients with hepatitis B e antigen (HBeAg) negative chronic hepatitis B. Journal of Pharmaceutical Sciences 2003; 92(7): 1386 doi: 10.1002/jps.10401
|
| 21 |
Jin Ding, Jun Liu, Cai-Fang Xue, Wei-Dong Gong, Ying-Hui Li, Ya Zhao. Anti-HBV effect of TAT- HBV targeted ribonuclease. World Journal of Gastroenterology 2003; 9(7): 1525-1528 doi: 10.3748/wjg.v9.i7.1525
|
| 22 |
Guo-Liang Zhang, Ye-Hong Wang, Wei Ni, Hui-Ling Teng, Zhi-Bin Lin. Hepatoprotective role of <italic>ganoderma lucidum</italic> polysaccharide against BCG-induced immune liver injury in mice. World Journal of Gastroenterology 2002; 8(4): 728-733 doi: 10.3748/wjg.v8.i4.728
|
| 23 |
Rong-Nan Chien, Yun-Fan Liaw. Thymalfasin for the treatment of chronic hepatitis B. Expert Review of Anti-infective Therapy 2004; 2(1): 9 doi: 10.1586/14787210.2.1.9
|
| 24 |
Zheng-Wen Liu, Qun-Ying Han, Ni Zhang, Wen Kang. Sequential changes of serum ferritin levels and their clinical significance in lamivudine-treated patients with chronic viral hepatitis B. World Journal of Gastroenterology 2004; 10(7): 972-976 doi: 10.3748/wjg.v10.i7.972
|
| 25 |
R‐N. Chien, C‐Y. Lin, C‐T. Yeh, Y‐F. Liaw. Hepatitis B virus genotype B is associated with better response to thymosin α1 therapy than genotype C. Journal of Viral Hepatitis 2006; 13(12): 845 doi: 10.1111/j.1365-2893.2006.00761.x
|